Leaflet CEREZYME 200U powder for concentrate for solution for infusion
Indicated for: Gaucher disease
Route of administration: infusion
Substance: imiglucerase (recombinant enzyme replacement)
ATC: A16AB02 (Alimentary tract and metabolism | Other alimentary tract and metabolism products | Enzymes)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Imiglucerase is a medication used to treat Gaucher disease, a rare genetic disorder caused by a deficiency of the enzyme glucocerebrosidase. It works by replacing the missing enzyme, helping to break down accumulated glucocerebroside in cells and reducing disease symptoms.
The medication is administered via intravenous infusion, usually once every two weeks, under the supervision of a specialist.
Side effects may include infusion site reactions, headache, fever, or fatigue. In rare cases, severe allergic reactions may occur.
Patients should be closely monitored during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
General data about CEREZYME 200U
- Substance: imiglucerase
- Date of latest medicines list: 01-07-2015
- Product code: W08252001
- Concentration: 200U
- Pharmaceutical form: powder for concentrate for solution for infusion
- Quantity: 1
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for imiglucerase
- 200U
- 400U